Cardiovascular

300 publications in "Cardiovascular"

Nov-10

Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes

Cardiovascular Endocrinology

Read more

Nov-10

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

Cardiovascular Neurology Respiratory

Read more

Nov-10

Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes: Incidence and Predictors

Cardiovascular Pharmacoepidemiology

Read more

Oct-10

Are there differences in cardiovascular and metabolic risk profiles among men and women with Type2 diabetes? A cross-sectional analysis

Cardiovascular Endocrinology

Read more

Oct-10

Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes

Cardiovascular Gastroenterology Pharmacoepidemiology

Read more

Oct-10

Chronic Hepatitis C Virus Infection Does Not Increase Risk of Incident Myocardial Infarction

Cardiovascular Virology and Immunisations

Read more

Sep-10

Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database

Cardiovascular Pharmacoepidemiology

Read more

Aug-10

SSRI and Risk of Congenital Cardiac Abnormalities

Cardiovascular Gynecology and Obstetrics Paediatrics Pharmacoepidemiology

Read more

Aug-10

Risk of heart failure with dopamine agonist use in Parkinson’s disease

Cardiovascular Neurology Pharmacoepidemiology

Read more

Aug-10

Risk of Myocardial Infarction in UK Primary Care Patients with Hepatitis C Virus Infection

Cardiovascular Virology and Immunisations

Read more

Aug-10

Use of serotoninergic medications and cardiac valvulopathy: A nested case- control study in the Health Improvement Network (THIN) Database.

Cardiovascular Pharmacoepidemiology

Read more

Aug-10

Risk of Cardiac Valve Regurgitation with Dopamine Agonist Use in Parkinson’s Disease and Hyperprolactinemia

Cardiovascular Neurology Pharmacoepidemiology

Read more
Date Title Categories
Nov-10 Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes

Cardiovascular Endocrinology

Nov-10 Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

Cardiovascular Neurology Respiratory

Nov-10 Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes: Incidence and Predictors

Cardiovascular Pharmacoepidemiology

Oct-10 Are there differences in cardiovascular and metabolic risk profiles among men and women with Type2 diabetes? A cross-sectional analysis

Cardiovascular Endocrinology

Oct-10 Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes

Cardiovascular Gastroenterology Pharmacoepidemiology

Oct-10 Chronic Hepatitis C Virus Infection Does Not Increase Risk of Incident Myocardial Infarction

Cardiovascular Virology and Immunisations

Sep-10 Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database

Cardiovascular Pharmacoepidemiology

Aug-10 SSRI and Risk of Congenital Cardiac Abnormalities

Cardiovascular Gynecology and Obstetrics Paediatrics Pharmacoepidemiology

Aug-10 Risk of heart failure with dopamine agonist use in Parkinson’s disease

Cardiovascular Neurology Pharmacoepidemiology

Aug-10 Risk of Myocardial Infarction in UK Primary Care Patients with Hepatitis C Virus Infection

Cardiovascular Virology and Immunisations

Aug-10 Use of serotoninergic medications and cardiac valvulopathy: A nested case- control study in the Health Improvement Network (THIN) Database.

Cardiovascular Pharmacoepidemiology

Aug-10 Risk of Cardiac Valve Regurgitation with Dopamine Agonist Use in Parkinson’s Disease and Hyperprolactinemia

Cardiovascular Neurology Pharmacoepidemiology

1 21 22 23 24 25